Your browser doesn't support javascript.
loading
Screening and Treatment for Iron Deficiency Anemia in Women: Results of a Survey of Obstetrician-Gynecologists.
Marcewicz, Lauren H; Anderson, Britta L; Byams, Vanessa R; Grant, Althea M; Schulkin, Jay.
Afiliação
  • Marcewicz LH; Division of Blood Disorders, National Center of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Mail Stop E-64, 1600 Clifton Road, Atlanta, GA, 30333, USA. Lauren.Marcewicz@va.gov.
  • Anderson BL; Atlanta VAMC, 1670 Clairmont Road, Decatur, GA, 30033, USA. Lauren.Marcewicz@va.gov.
  • Byams VR; Research Department, American Congress of Obstetricians and Gynecologists, PO Box 70620, Washington, DC, 20024, USA.
  • Grant AM; Division of Blood Disorders, National Center of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Mail Stop E-64, 1600 Clifton Road, Atlanta, GA, 30333, USA.
  • Schulkin J; Division of Blood Disorders, National Center of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Mail Stop E-64, 1600 Clifton Road, Atlanta, GA, 30333, USA.
Matern Child Health J ; 21(8): 1627-1633, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28251440
ABSTRACT
Objective To better understand the knowledge, attitudes and practices of obstetrician-gynecologists with respect to screening and treatment for iron deficiency anemia (IDA). Methods A total of 1,200 Fellows and Junior Fellows of the American College of Obstetricians and Gynecologists were invited to participate in a survey on blood disorders. Respondents completed a questionnaire regarding their patient population, screening and treatment practices for IDA, and general knowledge about IDA and its risk factors. Results Overall response rate was 42.4%. Thirty-eight percent of respondents screen non-pregnant patients regularly, based on risk factors; 30.5% screen only when symptoms of anemia are present. For pregnant patients, 50.0% of respondents screen patients at their initial visit, while 46.2% screen every trimester. Sixty-one percent of respondents supplement pregnant patients when there is laboratory evidence of anemia; 31.6% supplement all pregnant patients. Forty-two percent of respondents screen post-partum patients based on their risk factors for IDA. However, when asked to identify risk factors for post-partum anemia, slightly more than half of respondents correctly identified young age and income level as risk factors for post-partum anemia; only 18.9% correctly identified pre-pregnancy obesity as a risk factor. Conclusion There are opportunities for increased education on IDA for obstetrician-gynecologists, specifically with respect to risk factors. There also appears to be substantial practice variance regarding screening and supplementation for IDA, which may correspond to variability in professional guidelines. Increased education on IDA, especially the importance of sociodemographic factors, and further research and effort to standardize guidelines is needed.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Padrões de Prática Médica / Conhecimentos, Atitudes e Prática em Saúde / Anemia Ferropriva / Ginecologia / Obstetrícia Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Padrões de Prática Médica / Conhecimentos, Atitudes e Prática em Saúde / Anemia Ferropriva / Ginecologia / Obstetrícia Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Ano de publicação: 2017 Tipo de documento: Article